NIASPAN Drug Patent Profile

Which patents cover Niaspan, and what generic alternatives are available?

Niaspan is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in NIASPAN is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Niaspan

A generic version of NIASPAN was approved as niacin by BARR on April 14^th, 2005.

Summary for NIASPAN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	212
Clinical Trials:	45
Patent Applications:	4,162
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for NIASPAN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for NIASPAN
What excipients (inactive ingredients) are in NIASPAN?	NIASPAN excipients list
DailyMed Link:	NIASPAN at DailyMed

See drug prices for NIASPAN

See drug sales revenues for NIASPAN

Recent Clinical Trials for NIASPAN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pharmena North America	Phase 1
Cortria Corporation	Phase 1
PPD	Phase 1

See all NIASPAN clinical trials

US Patents and Regulatory Information for NIASPAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-004	Jul 28, 1997		DISCN	Yes	No
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997		DISCN	Yes	No
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-001	Jul 28, 1997		DISCN	No	No
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-002	Jul 28, 1997		DISCN	Yes	No
Abbvie	NIASPAN TITRATION STARTER PACK	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-005	Jul 28, 1997		DISCN	No	No

Expired US Patents for NIASPAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-004	Jul 28, 1997
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-002	Jul 28, 1997
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-001	Jul 28, 1997
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-004	Jul 28, 1997
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997

International Patents for NIASPAN

See the table below for patents covering NIASPAN around the world.

Country	Patent Number	Title	Estimated Expiration
Brazil	9815457
Canada	2297756	PROCEDES DE TRAITEMENT PROPHYLACTIQUE DE SUJETS ENCLINS A L'HYPERLIPIDEMIE A L'AIDE D'UN AGENT INHIBANT LES BOUFFEES VASOMOTRICES AVANT D'ENTAMER UNE THERAPIE A BASE D'ACIDE NICOTINIQUE SOUS FORME DE DOSE QUOTIDIENNE UNIQUE DE MANIERE A REDUIRE LES BOUFFEES VASOMOTRICES PROVOQUEES PAR L'ACIDE NICOTINIQUE (METHODS OF PRETREATING HYPERLIPIDEMIC INDIVIDUALS WITH A FLUSH INHIBITING AGENT PRIOR TO THE START OF SINGLE DAILY DOSE NICOTINIC ACID THERAPY TO REDUCE FLUSHING PROVOKED BY NICOTINIC ACID)
Australia	4751802
Canada	2591710
Australia	6454598
Australia	8605298
Germany	69829042